GOVX GeoVax Labs, Inc.

$1.37 +17.09%

Healthcare · Pharmaceutical Preparations

GeoVax Labs, Inc. (GOVX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $5 million. Shares last traded at $1.37, 72.0% below their 52-week high. Over the past year the stock is up 10.5%. Net profit margin is -862.3%, below the peer median of -0.1%. Revenue declined 37.1% year over year.

Market Cap

$5M

Shares Out

3.5M

EPS (TTM)

$-15.58

P/E Ratio

—

P/S Ratio

1.91

P/B Ratio

9.64

Dividend / Share

—

Dividend Yield

—

52-Week High

$4.90

52-Week Low

$0.12

Volume

7,468

Avg Vol (3m)

90,662.714

Performance

+12.30%

-31.16%

-3.86%

+311.29%

YTD

+558.02%

+10.48%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

44.16

SMA (50)

$1.57

SMA (200)

$1.21

Price vs SMA50

-12.55%

Price vs SMA200

+12.86%

ATR (14)

$0.34

Financials

Revenue

$2M

Net Income

$-21M

Gross Margin

—

Operating Margin

-869.3%

Net Margin

-862.3%

Return on Equity

-4347.1%

Return on Assets

-719.7%

Current Ratio

1.06

Debt / Equity

5.04

Revenue Growth (YoY)

-37.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-2.62	2026-05-14
FY 2025	$-22.40	2026-04-15
Q3 2025	$-0.97	2025-11-13
Q2 2025	$-0.79	2025-07-28
Q1 2026	$-11.20	2026-05-14
FY 2025	$-120.46	2026-04-15

Full earnings history →

Pharmaceutical Preparations peers

GOVX vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

1.91 / 3.54 med

-46% discount

Net margin vs peers

-862.3% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.